Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent
Łukasz Uram, Joanna Markowicz, Maria Misiorek, Aleksandra Filipowicz-Rachwał, Stanisław Wołowiec, Elżbieta Wałajtys-Rode
Topics & Concepts
TemozolomideCelecoxibGliomaCancer researchChemistryPoly(amidoamine)ApoptosisPharmacologyCytotoxicityDendrimerMedicineBiochemistryIn vitroAmidoamineDendrimers and Hyperbranched PolymersChemical Synthesis and AnalysisRNA Interference and Gene Delivery